Free Trial

JPMorgan Chase & Co.'s Rating of Amgen on 1/29/2016

On January 29, 2016, JPMorgan Chase & Co. updated its outlook on Amgen (NASDAQ:AMGN) with the action "Lower Price Target", setting a price target of $165.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from JPMorgan Chase & Co.

DateCompanyAction
11/2/2026
Mobileye Global Inc. stock logo
MBLY
Mobileye Global
Lower Price Target
11/2/2026
Pampa Energia S.A. stock logo
PAM
Pampa Energia
Lower Price Target
11/2/2026
Federated Hermes, Inc. stock logo
FHI
Federated Hermes
Boost Price Target
11/2/2026
Kinder Morgan, Inc. stock logo
KMI
Kinder Morgan
Boost Price Target
11/2/2026
Methanex Corporation stock logo
MEOH
Methanex
Boost Price Target
11/2/2026
OneMain Holdings, Inc. stock logo
OMF
OneMain
Boost Price Target
More Ratings From JPMorgan Chase & Co.